NAROPIN INJECTION 1%
Product details
Registration number: SIN09264P
Classification: Prescription Only
Active ingredients: ROPIVACAINE HCl
Strength: 10 mg/ml
Dosage form: INJECTION
Route: SUBCUTANEOUS; EPIDURAL
Registrant: DCH AURIGA SINGAPORE
ATC code: Pending
HSA approval date: 26 March 1997
Manufacturer(s):
- ASTRAZENECA AB
- ASPEN Notre Dame de Bondeville
Manufacturing country/countries: FRANCE; SWEDEN
What are the HSA registration number and classification for NAROPIN INJECTION 1%?
According to the HSA dataset updated 7 August 2026:
Registration number: SIN09264P
Classification: Prescription Only
What active ingredients and strength are recorded for NAROPIN INJECTION 1%?
According to the HSA dataset updated 7 August 2026:
Active ingredients: ROPIVACAINE HCl
Strength: 10 mg/ml
Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.
What dosage form and route are recorded for NAROPIN INJECTION 1%?
According to the HSA dataset updated 7 August 2026:
Dosage form: INJECTION
Route: SUBCUTANEOUS; EPIDURAL
Who is the recorded registrant for NAROPIN INJECTION 1%?
According to the HSA dataset updated 7 August 2026:
Registrant: DCH AURIGA SINGAPORE
Which manufacturers and countries are listed for NAROPIN INJECTION 1%?
According to the HSA dataset updated 7 August 2026:
Manufacturer(s):
- ASTRAZENECA AB
- ASPEN Notre Dame de Bondeville
Manufacturing country/countries: FRANCE; SWEDEN
Where can I look up NAROPIN INJECTION 1% in the HSA register?
Open HSA’s therapeutic product register and search for registration number SIN09264P or the exact product name NAROPIN INJECTION 1%. The general register link does not preselect this product.
What are the source dates for this NAROPIN INJECTION 1% record?
This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.
The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.
Has this NAROPIN INJECTION 1% record had a separate HSA register check?
No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.
Search the HSA register using SIN09264P for the latest record.
Sources and dates
HSA dataset: 2026. Updated: 13 November 2026.
Factual product information only; no dosing, treatment or suitability advice.
Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.
.png)